InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
Joseph A. Tyndall
2 Sep 2026
Director
Sold on a plan
3,500
$49.70
$173.94K
Amy McBride Wendell
11 Aug 2026
Director
Sold after exercise
13,353
$48.42
$646.59K
Marc A Began
10 Aug 2026
EVP & General Counsel
Sold after exercise
67,500
$47.35
$3.20M
Kathy Johnson Weiler
7 Aug 2026
Director
Sold on a plan
14,150
$45.30
$640.97K
Amy McBride Wendell
8 May 2026
Director
Sold after exercise
1,647
$42.60
$70.16K
Doris Quackenbush
7 May 2026
Sales VP
Sell
3,878
$43.51
$168.72K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
573
$43.67
$25.02K
Lindsey Marie Hartley
7 May 2026
CFO
Sold after exercise
478
$43.67
$20.87K
Jens Kemp
7 May 2026
Chief Marketing Officer
Sell
4,000
$43.44
$173.76K
Kathy Johnson Weiler
7 May 2026
Director
Sold after exercise
16,344
$44.09
$720.62K
John Johnson
7 May 2026
Director
Sold after exercise
11,050
$43.26
$477.97K
Erick Wayne DeVinney
16 Mar 2026
Chief Innovation Officer
Sold after exercise
5,221
$32.84
$171.46K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
6,580
$29.55
$194.44K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
21,825
$29.55
$644.86K
Kathy Johnson Weiler
16 Dec 2025
Director
Sold after exercise
18,248
$29.55
$539.17K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
18,248
$29.31
$534.89K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
20,436
$29.31
$599.02K
Amy McBride Wendell
16 Dec 2025
Director
Sold after exercise
5,000
$29.31
$146.56K
Lindsey Marie Hartley
15 Dec 2025
CFO
Sold after exercise
14,812
$29.86
$442.29K
Marc A Began
11 Dec 2025
EVP & General Counsel
Sell
13,222
$30.00
$396.66K
Michael D Dale
10 Dec 2025
Chief Executive Officer
Sell
25,000
$30.00
$750.00K
John Johnson
9 Dec 2025
Director
Sold after exercise
13,141
$29.98
$393.99K
John Johnson
9 Dec 2025
Director
Sold after exercise
8,545
$29.98
$256.20K
Paul Thomas
9 Dec 2025
Director
Sell
21,399
$29.61
$633.71K
Marc A Began
9 Dec 2025
EVP & General Counsel
Sell
9,278
$31.21
$289.55K
Jens Kemp
9 Dec 2025
Chief Marketing Officer
Sell
8,156
$31.21
$254.53K
Erick Wayne DeVinney
9 Dec 2025
Chief Innovation Officer
Sell
19,517
$31.21
$609.09K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
10,860
$30.98
$336.41K
Joseph A. Tyndall
9 Dec 2025
Director
Sold after exercise
14,248
$30.98
$441.36K
Michael D Dale
9 Dec 2025
Chief Executive Officer
Sell
61,463
$31.21
$1.92M
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
2,854
$31.56
$90.07K
Lindsey Marie Hartley
8 Dec 2025
CFO
Sold after exercise
11,533
$31.56
$363.94K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,891
$31.22
$371.27K
John Johnson
8 Dec 2025
Director
Sold after exercise
11,802
$31.26
$368.93K
William P. Mr. Burke
11 Nov 2025
Director
Sold after exercise
3,591
$24.02
$86.25K
William P. Mr. Burke
10 Nov 2025
Director
Sold after exercise
19,227
$24.01
$461.64K

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 25
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 910,696
History held since 24 Sep 2007